Key Statistics
Market Cap$444.16M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$3.95
52W High$8.63
52W Low$3.76
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
Employees2,700
Price Performance
1 Week+8.94%
3 Month-22.64%
1 Year-41.57%
FinancialsAnnual · QuiverQuant
Revenue$753.20M
Assets$1.15B
Liabilities$363.30M
Net Income$263.30M loss
About
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze MYGN with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.